Prescription drug prices are rising, and a new report from the Federal Trade Commission (FTC) explains why. Pharmacy benefit ...
The Federal Trade Commission (FTC) on Tuesday released its second interim report on pharmacy benefit managers (PBM), saying ...
On Tuesday, the Federal Trade Commission released its second interim staff report on prescription drug middlemen. The report ...
Regulators published their most detailed findings yet on how some of the nation’s largest companies profited from "excess" ...
The Arkansas Pharmacists Association is calling for public and legislative support for stronger regulation of Pharmacy ...
Pharmacy benefit managers, which serve as the middlemen between drug makers, insurers and pharmacies, reaped $7.3 billion in ...
For the second time in less than a year, the FTC has released a highly critical report of pharmacy benefit managers, or PBMs.
The Federal Trade Commission on Tuesday released an interim report saying that powerful drug middlemen marked up drugs for ...
CVS Caremark, Express Scripts and OptumRx dramatically mark up specialty generic drugs to affiliated pharmacies, the Federal ...
The nation's three largest pharmacy benefit managers have significantly marked up the prices of certain medicines, including ...
"While this information is theoretically available to the public, institutional owners' holdings are challenging to identify ...